Novartis @Novartis · 11 Jul 2026
@Novartis I'm eagerly awaiting the launch of Rhapsido in Japan. As it’s a treatment for chronic urticaria that requires long-term use, I hope for an affordable price point.
43Views
0Likes
0Reposts
1Replies
0Quotes
0Bookmarks
Is that a lot?
0.02×vs this author's median2 246 views is typical
20Percentile for this authorof 5 recent posts
0.01%Reachviews ÷ followers
2.33%Engagement rateof viewers reacted